International Medical Management Corp.

Effective medicines and medical products are essential to maintaining good health and longevity. New medicines, medical products and technologies are being developed, manufactured and distributed all over the world for those who need them.
However, under current circumstances, these effective medicines are not always available to some countries due to government regulations, economic conditions, or for strategic business reasons.

In Japan, regulation of medicines and medical products is highly restrictive and the government approval process to obtain authorization is very costly and time consuming.
As a result, many foreign pharmaceutical and medical device manufacturers spend millions of dollars and years to obtain formal approval for their products.
In many cases, they abandon their efforts as the process becomes cost prohibitive. Ultimately, Japanese patients are left without access to effective medicines and products from abroad.

In order to overcome this dilemma, Japan’s Pharmaceutical and Medical Device Act (PMD Act) provides exemptions to allow the lawful import of certain ‘unapproved’ medicines and medical products. International Medical Management Corporation (IMMC) provides assistance to physicians wishing to import unapproved medicines from abroad in accordance with the PMD Act.

International Medical Management Corporation (IMMC) was established in 2006 to provide medical supply consulting services to the Japanese healthcare community.
Since 2008, we have been involved in direct importation of drugs in response to requests from medical institutions and pharmaceutical manufacturers.
At the same time, we have developed a safe and quick delivery system in cooperation with logistics companies.
We focus on listening to medical institutions and healthcare professionals to bring solid and stress-free access to drugs and medical equipment.
IMMC endeavours to offer services to doctors in meeting their patients' unmet medical needs ensuring stable supply, fast delivery and legal importation of unapproved medicines.

IMMC has served more than 1,300 hospitals and clinics throughout Japan. We have earned a high reputation for our safe, quick and lawful importation.

Our main focus is on vaccines including hepatitis A, hepatitis B, hepatitis A + hepatitis B, typhoid, meningococcal serogroup B, quadrivalent meningitis, rabies, cholera (oral), MMR, Japanese encephalitis, 3-in-1 (diphtheria, tetanus, pertussis).

Field

Working with our parent company, the Clinigen Group, IMMC teams up with suppliers from all around the world to provide prompt and safe delivery of medications to physicians.